文献速递肿瘤 PET/CT放射性药物与辐射防护

FDG-PET显像系统性RNA癌症疫苗免疫应答

In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET.
PubMed 文献 · EJNMMI Res · 2018-08-15

本研究利用FDG-PET/MRI分析小鼠经RNA-脂质复合物疫苗刺激后脾脏T细胞免疫,观察到脾脏葡萄糖摄取快速短暂增加并与抗原特异性T细胞活化相关;一例参与四价RNA-脂质复合物癌症疫苗1期试验的黑色素瘤患者显示脾脏FDG摄取增加,表明FDG-PET/CT有潜力显像免疫治疗中的免疫激活过程。

要点

  • 小鼠接种RNA-脂质复合物疫苗后脾脏FDG摄取快速短暂增加,先于T细胞增殖。
  • 脾脏FDG摄取与抗原特异性T细胞活化及RNA剂量相关。
  • 一例黑色素瘤患者显示脾脏FDG摄取增加,提示临床可显像免疫激活。

核心结论

  • 临床前结果显示接种疫苗后脾脏FDG摄取快速短暂增加,反映先于T细胞增殖的免疫激活。
  • 患者的FDG-PET/CT也能显像这种免疫激活,为FDG-PET/CT显像新型免疫治疗中的免疫过程提供了新潜在应用。

研究设计与样本

  • 临床前研究采用系统性给予编码Moloney鼠白血病病毒内源性抗原gp70的RNA-脂质复合物,通过FDG-PET/MRI分析小鼠脾脏T细胞免疫。
  • 临床可行性在一例参与四价RNA-脂质复合物癌症疫苗1期试验的黑色素瘤患者中展示。

主要发现

  • 与其它器官相比,脾脏葡萄糖摄取独家增加,归因于脂质体介导的RNA靶向该免疫相关器官。
  • 小鼠脾脏体内和离体FDG摄取分析与抗原特异性T细胞活化良好相关。
  • 使用无关(抗原非特异性)RNA也导致接种后早期FDG摄取增强,通过激活其他脾细胞群体。
  • 葡萄糖摄取也依赖于给予的RNA剂量,与增殖抗原特异性T细胞的活化和频率以及脾细胞群体的一般活化模式一致。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: [18F]Fluoro-2-deoxy-2-D-glucose positron emission tomography (FDG-PET) is commonly used in the clinic for diagnosis of cancer and for follow-up of therapy outcome. Additional to the well-established value in tumor imaging, it bears potential to depict immune processes in modern immunotherapies. T cells enhance their glucose consumption upon activation and are crucial effectors for the success of such novel therapies. In this study, we analyzed the T cell immunity in spleen after antigen-specific stimulation of T cells via highly innovative RNA-based vaccines using FDG-PET/MRI. For this purpose, we employed systemic administration of RNA-lipoplexes encoding the endogenous antigen of Moloney murine leukemia virus (gp70) which have been previously shown to induce potent innate as well as adaptive immune mechanisms for cancer immunotherapy. Feasibility of clinical imaging of increased splenic FDG uptake was demonstrated in a melanoma patient participating in a clinical phase 1 trial of a tetravalent RNA-lipoplex cancer vaccine. RESULTS: We observed exclusive increase of glucose uptake in spleen compared to other organs thanks to liposome-mediated RNA targeting to this immune-relevant organ. In vivo and ex vivo FDG uptake analysis in the spleen of vaccinated mice correlated well with antigen-specific T cell activation. Moreover, the use of an irrelevant (antigen non-specific) RNA also resulted in enhanced FDG uptake early after vaccination through the activation of several other splenic cell populations. The glucose uptake was also dependent on the dose of RNA administered in line with the activation and frequencies of proliferating antigen-specific T cells as well as the general activation pattern of splenic cell populations. CONCLUSIONS: Our preclinical results show rapid and transient vaccination-induced increase of FDG uptake within the spleen reflecting immune activation preceding T cell proliferation. FDG-PET/CT in patients is also capable to image this immune activation resulting in a new potential application of FDG-PET/CT to image immune processes in new immunological therapies.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Pektor S, Hilscher L, Walzer KC, et al. In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET. EJNMMI Res. 2018. PMID: 30112704. doi:10.1186/s13550-018-0435-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。